Which country produces cycloserine?

Cycloserine (Cycloserine) is an early antibiotic used in anti-tuberculosis treatment. It was first successfully developed in the 1950s. It was first produced by American pharmaceutical companies by isolating Streptomyces orchidaceus, and was approved for marketing by the US FDA in 1955. As an oral preparation, the advent of cycloserine provided a new option for the treatment of drug-resistant tuberculosis at that time and was widely used in multi-drug combination therapy for tuberculosis. It can be said that the initial R&D and production background of cycloserine came from the United States, and it is one of the original drugs in the United States.

With the expiration of the patent period and the development of the pharmaceutical industry, the production of cycloserine has gradually expanded to other countries. Currently, many countries and regions in the world have cycloserine production capabilities, including India, South Korea and China. Especially with the epidemic of multi-drug-resistant tuberculosis, the World Health Organization (WHO) has included cycloserine in the list of second-line tuberculosis drugs, which has also promoted the development and global market supply of generic drugs. For example, South Korea's Daslecon is a generic version produced by Korean pharmaceutical companies, while China's Xilaixing is a representative of domestically produced cycloserine.

From the perspective of drug history, cycloserine was developed in the United States. However, as the demand for anti-tuberculosis drugs continues to grow, it has gradually formed a multi-country production and multi-channel supply pattern. At present, cycloserine maintains its clinical application value whether in the United States, Asia or other regions. The ingredients of cycloserine produced by pharmaceutical companies in different countries are basically the same, but there are differences in price, packaging, quality control standards and supply chain management. In general, cycloserine is an anti-tuberculosis drug that was developed in the United States and gradually promoted globally. It is an important component of multi-drug combination therapy for tuberculosis.

Reference materials:https://en.wikipedia.org/wiki/Cycloserine